Drugs / Bilirubin
Bilirubin
also known as
(4z,15z)-bilirubin ix.alpha. · Bilirubin ix.alpha. · Bilirubin test · Cholerythrin · Hematoidin · NSC-26685
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00692510 Background | Nov 2007 → Sep 2008 | Alzheimer disease | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bilirubin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00692510 ↗ |
| Known as | (4z,15z)-bilirubin ix.alpha. | ChEMBL registry synonym — accepted as the source's own label CHEMBL501680 ↗ |
| Known as | Bilirubin ix.alpha. | ChEMBL registry synonym — accepted as the source's own label CHEMBL501680 ↗ |
| Known as | Bilirubin test | ChEMBL registry synonym — accepted as the source's own label CHEMBL501680 ↗ |
| Known as | Cholerythrin | ChEMBL registry synonym — accepted as the source's own label CHEMBL501680 ↗ |
| Known as | Hematoidin | ChEMBL registry synonym — accepted as the source's own label CHEMBL501680 ↗ |
| Known as | NSC-26685 | ChEMBL registry synonym — accepted as the source's own label CHEMBL501680 ↗ |
| Modality | Small molecule | — CHEMBL501680 ↗ |